NCT04383015 is a NA clinical trial of Exercise strategies in Type 1 Diabetes, sponsored by York University.

Who is sponsoring NCT04383015?

NCT04383015 is sponsored by York University.

What drugs are being tested in NCT04383015?

Interventions in NCT04383015: Exercise strategies.

What condition does NCT04383015 study?

NCT04383015 studies Type 1 Diabetes.

Is NCT04383015 still recruiting?

NCT04383015 is currently completed. Last updated 11 May 2020.

Last reviewed 2020-05-11 · How we verify

NCT04383015

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carbohydrate and Insulin Requirements During Prolonged Fasted Exercise

Completed NA Last updated 11 May 2020

What this trial tests

NA trial testing Exercise strategies in Type 1 Diabetes in 15 participants. Completed in 17 October 2019.

Timeline

31 October 2018

Primary endpoint
16 October 2019

17 October 2019

Quick facts

Lead sponsor	York University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	15
Start date	31 October 2018
Primary completion	16 October 2019
Estimated completion	17 October 2019
Sites	1 location across Canada

Drugs / interventions tested

Exercise strategies

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

York University

Who can join

Adults 18 to 65, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the time spent in glucose target range (4.0-10.0 mmol/L) during exercise and in recovery using three different management strategies for prolonged aerobic exercise: A) carbohydrate dose of 0.3g/kg/hr; B) A 50 percent basal rate reduction, performed 90-minutes in advance of exercise for the duration of the activity; and C) A 50 percent basal rate reduction, performed at exercise onset, with carbohydrate dose of 0.3g/kg/hr

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
McGaugh SM, Zaharieva DP, Pooni R, D'Souza NC, et al · · 2021 · cited 14× · PMID 33328284 · DOI 10.2337/dc20-1554

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other York University trials

Trials by the same sponsor.

NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
NCT07312409 — Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? · NA · not yet recruiting
NCT07418320 — Grow Together, Thrive Together: A Feasibility Study of a Brief Relationship Intervention for Emerging Adults and Their C · NA · not yet recruiting
NCT07351630 — Building Blocks for Child and Family Well-being · NA · recruiting
NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04383015 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by York University
Last refreshed: 11 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04383015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing